AbbVie
ABBV
ABBV
1,500 hedge funds and large institutions have $72.7B invested in AbbVie in 2014 Q3 according to their latest regulatory filings, with 105 funds opening new positions, 581 increasing their positions, 588 reducing their positions, and 50 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
7.96% more ownership
Funds ownership: 71.06% → 79.02% (+8%)
3% more funds holding
Funds holding: 1,456 → 1,500 (+44)
1% less repeat investments, than reductions
Existing positions increased: 581 | Existing positions reduced: 588
Holders
1,500
Holding in Top 10
80
Calls
$1.05B
Puts
$449M
Top Buyers
| 1 | +$1.4B | |
| 2 | +$882M | |
| 3 | +$751M | |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
+$622M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$560M |
Top Sellers
| 1 | -$659M | |
| 2 | -$324M | |
| 3 | -$290M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$211M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$196M |